IP Library › Assignment 040217/0172
Patent Assignment
Reel/Frame 040217/0172

Assignment of Assignor's Interest

Recorded: 2016-11-03 Pages: 3
Assignors
QUINN, JOHN FREDERICK
Executed: 2013-09-09
KHLEBNIKOV, VLADIMIR
Executed: 2013-08-06
Assignee
RVX THERAPEUTICS INC.
202,279 MIDPARK WAY SE, CALGARY, AB, T2X 1M2, CANADA
Covered Property (1)
Novel Quinazolinones as Bromodomain Inhibitors
Patent: 9,855,271 →
Application: 14/908,898 →
Publication: US 2016/0193218
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
General Conveyance and Assumption Agreement Nov 3, 2016
From: RVX THERAPEUTICS INC.
To: ZENITH EPIGENETICS CORP.
Reel/Frame 040561/0863 →
Change of Name Dec 21, 2016
From: ZENITH EPIGENETICS CORP.
To: ZENITH CAPITAL CORP.
Reel/Frame 041120/0548 →
Assignment of Assignor's Interest Dec 23, 2016
From: ZENITH CAPITAL CORP.
To: ZENITH EPIGENETICS LTD.
Reel/Frame 041182/0891 →